Pd05-03 efficacy and safety of lumasiran in patients with primary hyperoxaluria type 1: 24-month analysis of the illuminate-a trial

Journal of Urology(2022)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要